120 related articles for article (PubMed ID: 8450182)
1. The preliminary observation on immunosuppressive effect of norcantharidin in mice.
Yan MS; Xiue S; Wei LX; Piao XH
Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):79-85. PubMed ID: 8450182
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival.
Hsieh CH; Liao HF; Kuo CD; Huang YC; Shueng PW; Hsu YP; Wang LY; Tsai TH; Chen YJ
Transplantation; 2011 Oct; 92(8):848-57. PubMed ID: 21876479
[TBL] [Abstract][Full Text] [Related]
3. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.
Liu XH; Blazsek I; Comisso M; Legras S; Marion S; Quittet P; Anjo A; Wang GS; Misset JL
Eur J Cancer; 1995 Jun; 31A(6):953-63. PubMed ID: 7646929
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
Yi SN; Wass J; Vincent P; Iland H
Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
[TBL] [Abstract][Full Text] [Related]
5. Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.
Liu XH; Blazsek I; Breard J; Comisso M; Mathe G; Misset JL
Drugs Exp Clin Res; 1991; 17(9):419-26. PubMed ID: 1822434
[TBL] [Abstract][Full Text] [Related]
6. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro].
Li LX; Tang YM; Zhang HZ; Shen HQ; Qian BQ; Luo CF
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):493-7. PubMed ID: 19099803
[TBL] [Abstract][Full Text] [Related]
8. [Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carboncyclic analogs of norcantharidin].
Fang Y; Tian SL; Li KQ; Zhao SW; Wang ZY
Yao Xue Xue Bao; 1993; 28(12):931-5. PubMed ID: 8030418
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years.
Zhou J; Ren Y; Tan L; Song X; Wang M; Li Y; Cao Z; Guo C
Biomed Pharmacother; 2020 Nov; 131():110755. PubMed ID: 33152920
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis and anticancer activity of norcantharidin-galactose derivatives].
Fan F; Sun XF
Yao Xue Xue Bao; 2008 Feb; 43(2):157-61. PubMed ID: 18507342
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effect of stepronin (TS-5010680) in mice.
de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
[No Abstract] [Full Text] [Related]
13. Effect of norcantharidin on the human breast cancer Bcap-37 cells.
Liu D; Shi P; Yin X; Chen Z; Zhang X
Connect Tissue Res; 2012; 53(6):508-12. PubMed ID: 22606958
[TBL] [Abstract][Full Text] [Related]
14. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer.
Li XY; Guan QX; Shang YZ; Wang YH; Lv SW; Yang ZX; Wang R; Feng YF; Li WN; Li YJ
World J Gastroenterol; 2021 Jul; 27(26):4208-4220. PubMed ID: 34326620
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells.
Chen YJ; Shieh CJ; Tsai TH; Kuo CD; Ho LT; Liu TY; Liao HF
Anticancer Drugs; 2005 Mar; 16(3):293-9. PubMed ID: 15711181
[TBL] [Abstract][Full Text] [Related]
16. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.
Zhou WL; Wu JM; Wu QL; Wang JX; Zhou Y; Zhou R; He PL; Li XY; Yang YF; Zhang Y; Li Y; Zuo JP
Acta Pharmacol Sin; 2005 Nov; 26(11):1352-8. PubMed ID: 16225758
[TBL] [Abstract][Full Text] [Related]
17. [Studies on anti-tumor agents. I: Synthesis and anti-cancer activity of amino acid derivatives of norcantharidin].
Tian SL; Zhao SW; Zhu AT; Fang Y; Li KQ
Yao Xue Xue Bao; 1993; 28(11):870-5. PubMed ID: 8010005
[TBL] [Abstract][Full Text] [Related]
18. Selective suppression by prodigiosin of the mitogenic response of murine splenocytes.
Nakamura A; Nagai K; Ando K; Tamura G
J Antibiot (Tokyo); 1986 Aug; 39(8):1155-9. PubMed ID: 2944863
[TBL] [Abstract][Full Text] [Related]
19. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A.
Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.
Mo L; Zhang X; Shi X; Wei L; Zheng D; Li H; Gao J; Li J; Hu Z
Cancer Sci; 2018 Jul; 109(7):2109-2118. PubMed ID: 29770533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
